Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC gynaecological cancer cooperative group study

H. C. Wagenaar, N. Colombo, I. Vergote, G. Hoctin-Boes, G. Zanetta, S. Pecorelli, A. J. Lacave, Q. Van Hoesel, A. Cervantes, G. Bolis, M. Namer, C. Lhommé, J. P. Guastalla, M. A. Nooij, A. Poveda, V. Scotto di Palumbo, J. B. Vermorken

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: An EORTC gynaecological cancer cooperative group study'. Together they form a unique fingerprint.

Medicine & Life Sciences